Financial reimbursement: an incentive to increase the supply of transplantable organs

D E Daniels1, J S Hollenback, R R Cox

  • 1Department of Applied Health Science at Indiana University, Bloomington 47405-3085, USA.

Insights

Financial incentives may boost organ donation rates among hesitant individuals. This study explored if monetary reimbursement increases organ donation, addressing disparities in organ availability for minority populations.

Area of Science:

  • Transplantation Medicine
  • Bioethics
  • Public Health

Background:

  • The demand for transplantable human organs significantly outstrips supply, a gap that is widening.
  • Minority populations, particularly African Americans, are underrepresented as organ donors compared to their demographic presence.
  • Historical data indicates lower organ donation rates among African Americans, Hispanics, and Asians.

Purpose of the Study:

  • To investigate the hypothesis that financial reimbursement can enhance organ donation.
  • To address the organ shortage by exploring incentives for potential donors hesitant to donate altruistically.

Main Methods:

  • The study design involved exploring the impact of financial reimbursement on organ donation decisions.
  • Data analysis focused on potential donors expressing reluctance based on altruism alone.

Main Results:

  • The study aimed to determine if financial incentives influence organ donation willingness.
  • Results are pending analysis of donor responses to financial reimbursement proposals.

Conclusions:

  • Financial incentives could be a viable strategy to increase organ donation rates.
  • Addressing donor hesitancy through reimbursement may help bridge the gap in organ availability, particularly for minority groups.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...